CIK 0001588978 · Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260199180
- Phone
- 6502329832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Waters Kevin EVP, CFO | Sale | −373 | $20.95 | $8K | 180,355 |
| 2026-08-13 | Waters Kevin EVP, CFO | Grant or award | +29,527 | 180,728 | ||
| 2026-08-13 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +40,851 | 40,851 | ||
| 2026-06-08 | Waters Kevin EVP, CFO | Sale | −357 | $28.48 | $10K | 151,201 |
| 2026-03-17 | Waters Kevin EVP, CFO | Sale | −706 | $28.15 | $20K | 151,558 |
| 2026-03-06 | Waters Kevin EVP, CFO | Sale | −6,721 | $23.70 | $159K | 152,264 |
| 2026-03-05 | Waters Kevin EVP, CFO | Grant or award | +47,462 | 158,985 | ||
| 2026-03-05 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +32,576 | 32,576 | ||
| 2026-02-19 | Waters Kevin EVP, CFO | Grant or award | +3,532 | 111,523 | ||
| 2025-03-18 | Waters Kevin EVP, CFO | Sale | −733 | $57.06 | $42K | 107,991 |
| 2025-03-06 | Waters Kevin EVP, CFO | Sale | −3,662 | $61.31 | $225K | 108,724 |
| 2025-03-03 | Waters Kevin EVP, CFO | Grant or award | +16,290 | 112,386 | ||
| 2025-03-03 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +14,388 | 14,388 | ||
| 2024-10-15 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +25,000 | $4.56 | $114K | 121,096 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −15,959 | $72.11 | $1.2M | 105,137 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −8,115 | $73.02 | $593K | 97,022 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −926 | $73.75 | $68K | 96,096 |
| 2024-10-15 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 19,160 | ||
| 2024-09-16 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +15,917 | $4.52 | $72K | 112,013 |
| 2024-09-16 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +9,083 | $4.56 | $41K | 121,096 |
Page 1 of 4 · 68 trades